Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?

Overview of attention for article published in Journal for Immunotherapy of Cancer, February 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 8 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy

Article in PLOS ONE (January 2024)

How Does Target Lesion Selection Affect RECIST? A Computer Simulation Study.

Article in Investigative Radiology (November 2023)

Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA

Article in Clinica Chimica Acta (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.